ATE201987T1 - Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure - Google Patents

Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure

Info

Publication number
ATE201987T1
ATE201987T1 AT98902707T AT98902707T ATE201987T1 AT E201987 T1 ATE201987 T1 AT E201987T1 AT 98902707 T AT98902707 T AT 98902707T AT 98902707 T AT98902707 T AT 98902707T AT E201987 T1 ATE201987 T1 AT E201987T1
Authority
AT
Austria
Prior art keywords
lewiss
inhibiting
decomposition
acid
fluoroether
Prior art date
Application number
AT98902707T
Other languages
German (de)
English (en)
Inventor
Christopher Bieniarz
Steve H Chang
Keith R Cromack
Shuyen L Huang
Toshikazu Kawai
Manami Kobayashi
David Loffredo
Rajagopalan Raghavan
Earl R Speicher
Honorate A Stelmach
Original Assignee
Abbott Lab
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25148366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE201987(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab, Central Glass Co Ltd filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE201987T1 publication Critical patent/ATE201987T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
AT98902707T 1997-01-27 1998-01-23 Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure ATE201987T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/789,679 US5990176A (en) 1997-01-27 1997-01-27 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
PCT/US1998/001376 WO1998032430A1 (en) 1997-01-27 1998-01-23 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid

Publications (1)

Publication Number Publication Date
ATE201987T1 true ATE201987T1 (de) 2001-06-15

Family

ID=25148366

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01107733T ATE320798T1 (de) 1997-01-27 1998-01-23 Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure
AT98902707T ATE201987T1 (de) 1997-01-27 1998-01-23 Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01107733T ATE320798T1 (de) 1997-01-27 1998-01-23 Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure

Country Status (27)

Country Link
US (6) US5990176A (enExample)
EP (2) EP0967975B1 (enExample)
JP (5) JP3183520B2 (enExample)
KR (1) KR100368672B1 (enExample)
CN (3) CN1899271A (enExample)
AR (2) AR011090A1 (enExample)
AT (2) ATE320798T1 (enExample)
AU (1) AU726733B2 (enExample)
BG (2) BG65414B1 (enExample)
BR (1) BR9806996A (enExample)
CA (2) CA2626424A1 (enExample)
CO (1) CO4920220A1 (enExample)
CZ (1) CZ297092B6 (enExample)
DE (2) DE69800928T2 (enExample)
DK (2) DK0967975T3 (enExample)
ES (2) ES2256104T3 (enExample)
GR (1) GR3036190T3 (enExample)
HU (1) HUP0002101A3 (enExample)
IL (1) IL130150A (enExample)
NO (1) NO993606L (enExample)
NZ (1) NZ335994A (enExample)
PL (1) PL334477A1 (enExample)
PT (2) PT967975E (enExample)
SK (1) SK284243B6 (enExample)
TR (1) TR199901579T2 (enExample)
WO (1) WO1998032430A1 (enExample)
ZA (1) ZA98418B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6162443A (en) * 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
EP1705852B1 (en) 1999-01-08 2010-02-10 Sony Deutschland Gmbh Synchronisation symbol structure for OFDM system
TW523409B (en) 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
JP4253343B2 (ja) * 2003-09-10 2009-04-08 クリスタリア プロデュトス キミコス ファーマシューティコス リミターダ 麻酔用フルオロエーテル化合物の安定した医薬組成物、フルオロエーテル化合物の安定化方法、フルオロエーテル化合物の分解を防止するための安定剤の使用
EP1871734A4 (en) * 2005-04-18 2010-08-04 Piramal Critical Care Inc PREPARATION OF SEVOFLURAN WITH LOW WATER CONTENT
WO2009049460A1 (en) * 2007-10-15 2009-04-23 Jiangsu Hengrui Medicine Co., Ltd. New packaging material for sevoflurane
PL2244737T3 (pl) * 2008-01-22 2020-05-18 The Board Of Regents Of The University Of Texas System Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu
US20090275785A1 (en) * 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
US8283643B2 (en) * 2008-11-24 2012-10-09 Cymer, Inc. Systems and methods for drive laser beam delivery in an EUV light source
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
US9278048B2 (en) * 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
BE1024432B1 (fr) 2016-11-02 2018-02-19 Central Glass Company, Limited Procédé pour le lavage de récipient de stockage de sévoflurane et procédé pour le stockage de sévoflurane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992276A (en) * 1959-05-20 1961-07-11 Du Pont Process for preparing polyfluoro alkyl compounds
US3527813A (en) * 1966-10-03 1970-09-08 Air Reduction 1,1,2 - trifluoro - 2 - chloroethyl difluoromethyl ether and its method of preparation
US3689571A (en) * 1970-07-31 1972-09-05 Baxter Laboratories Inc Fluorinated ether
GB1499818A (en) * 1974-12-06 1978-02-01 Ici Ltd Anaesthetic composition
US4250334A (en) * 1979-12-26 1981-02-10 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
US4469898A (en) * 1979-12-26 1984-09-04 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
JP2786108B2 (ja) * 1994-03-31 1998-08-13 セントラル硝子株式会社 フルオロメチル−１，１，１，３，３，３−ヘキサフルオロイソプロピルエーテルの精製方法
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Also Published As

Publication number Publication date
BR9806996A (pt) 2000-03-14
CN1152674C (zh) 2004-06-09
NO993606L (no) 1999-09-24
SK86199A3 (en) 2000-06-12
KR20000070482A (ko) 2000-11-25
JP3664648B2 (ja) 2005-06-29
DK1114641T3 (da) 2006-05-15
HUP0002101A3 (en) 2002-03-28
DE69833884T2 (de) 2006-08-24
DE69800928D1 (de) 2001-07-19
SK284243B6 (sk) 2004-12-01
NO993606D0 (no) 1999-07-23
BG109751A (bg) 2008-06-30
ES2256104T3 (es) 2006-07-16
US20060148906A1 (en) 2006-07-06
GR3036190T3 (en) 2001-10-31
CN1560003A (zh) 2005-01-05
IL130150A (en) 2004-09-27
ZA98418B (en) 1999-04-20
NZ335994A (en) 2000-08-25
PT1114641E (pt) 2006-05-31
EP1114641A2 (en) 2001-07-11
KR100368672B1 (ko) 2003-01-24
JP2005279283A (ja) 2005-10-13
AU726733B2 (en) 2000-11-16
HK1074434A1 (en) 2005-11-11
BG103656A (en) 2000-04-28
CO4920220A1 (es) 2000-05-29
EP0967975B1 (en) 2001-06-13
AU5930098A (en) 1998-08-18
CN1244797A (zh) 2000-02-16
US20030130359A1 (en) 2003-07-10
ES2170474T3 (es) 2002-08-01
US20020016373A1 (en) 2002-02-07
JP2001187729A (ja) 2001-07-10
JP2000510159A (ja) 2000-08-08
JP2006143742A (ja) 2006-06-08
AR011090A1 (es) 2000-08-02
DE69833884D1 (de) 2006-05-11
EP1114641A3 (en) 2003-05-28
CZ256199A3 (cs) 1999-11-17
ATE320798T1 (de) 2006-04-15
DK0967975T3 (da) 2001-09-17
CA2626424A1 (en) 1998-07-30
CN1321958C (zh) 2007-06-20
IL130150A0 (en) 2001-03-19
JP2006137769A (ja) 2006-06-01
US6444859B2 (en) 2002-09-03
PT967975E (pt) 2001-11-30
CA2278133A1 (en) 1998-07-30
CA2278133C (en) 2001-06-26
DE69800928T2 (de) 2001-11-22
EP1114641B1 (en) 2006-03-22
US20040048932A1 (en) 2004-03-11
HUP0002101A2 (hu) 2001-05-28
CZ297092B6 (cs) 2006-09-13
US6677492B2 (en) 2004-01-13
AR057610A2 (es) 2007-12-05
WO1998032430A1 (en) 1998-07-30
US5990176A (en) 1999-11-23
PL334477A1 (en) 2000-02-28
TR199901579T2 (xx) 1999-12-21
EP0967975A1 (en) 2000-01-05
JP3183520B2 (ja) 2001-07-09
US6288127B1 (en) 2001-09-11
BG65414B1 (bg) 2008-07-31
CN1899271A (zh) 2007-01-24

Similar Documents

Publication Publication Date Title
ATE320798T1 (de) Fluoroetherzusammensetzungen und verfahren zur hemmung ihrer zersetzung in gegenwart einer lewissäure
ATE277621T1 (de) Verfahren und zusammensetzungen zur prävention von toleranz von bronchodilatoren
DE60011391D1 (de) Verfahren und zusammensetzungen zur erhöhung der anzahl weisser blutzellen
DE69922309D1 (de) Verfahren zur Herstellung von Fettsäureestern
DE69318913D1 (de) Wasser- und ölabweisende Elemente und Verfahren zur ihrer Herstellung
DE69829427D1 (de) Verfahren zur Herstellung von wasserlöslichem Tricarboxypolysaccharid
DE69938304D1 (de) Verfahren zur herstellung von diglyceriden
DE69704014D1 (de) Verfahren zur Herstellung von konjugierter Linolsäure
DE69725488D1 (de) Verfahren zur Herstellung einer Asphaltzusammensetzung
EP1088333A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING BONE RESORPTION
DE59905749D1 (de) Verfahren zur herstellung von acrylsäure und acrylsäureestern
DE69709649D1 (de) Nachspülzusätze sowie verfahren zur verwendung zur freisetzung von parfümvorstufen
DE59909543D1 (de) Verfahren zur herstellung von 3-alkanoyl- und 3-alkylindolen
DE69822873D1 (de) Zusammensetzungen und verfahren zur gewichtsverringerung
DE69916755D1 (de) Verfahren zur Herstellung von Alkoholen
DE69937171D1 (de) Verfahren zur Herstellung von arylierten Poly-alpha-Olefinen
DE69302810D1 (de) Verbundwerkstoffe und verfahren zu ihrer herstellung
DE59900932D1 (de) Verfahren zur herstellung von acrylsäure und acrylsäureestern
DE69716420D1 (de) Bitumenzusammensetzungen und verfahren zu ihrer herstellung
DE59905752D1 (de) Verfahren zur herstellung von acrylsäure und acrylsäureestern
DE69835337D1 (de) Succinimid/ Hydroxycarbonsäure Copolymer und Verfahren zur Herstellung
DE60030661D1 (de) Verfahren zur Herstellung von Alkanolaminen und Vorrichtung zu ihrer Herstellung
DE59808528D1 (de) Verfahren zur Herstellung von 3-Glycidyloxypropyltrialkoxysilanen
DE69819457D1 (de) Phosphorsäureester, Verfahren zu seiner Herstellung und Verwendung davon
DE69915976D1 (de) Verfahren zur Herstellung von Naphthalindicarbonsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked